Remd Biotherapeutics Inc.

Camarillo, CA

UEI
DXA8DRFBBBM5
CAGE
74ZH7
Primary NAICS
Not on record
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Small Business Joint Venture
  • Limited Liability Company
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
4010 Adolfo Rd a, Camarillo, CA 93012, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Assessment of multiple dose administration ofglucagon receptor blocker REMD477 in type 1 diabetes R44DK108305 National Institute of Diabetes and Digestive and Kidney Diseases (NIH) $4,968,554
Assessment of the glucagon receptor blocker remd-477 on insulin requirements in type 1 diabetes R42DK108305 National Institutes of Health $1,653,666

Quick answers

Is Remd Biotherapeutics Inc. registered in SAM.gov?

Yes. Remd Biotherapeutics Inc.'s SAM.gov registration is active through June 10, 2027.

What is Remd Biotherapeutics Inc.'s most recent federal award?

Remd Biotherapeutics Inc.'s most recent federal grant award is Assessment of multiple dose administration ofglucagon receptor blocker REMD477 in type 1 diabetes (R44DK108305), from National Institute of Diabetes and Digestive and Kidney Diseases (NIH), on September 1, 2016.

On GovTribe

See Remd Biotherapeutics Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login